IBEC Seminar: David Caballero
Nanobioengineering group, IBEC. “The cell ratchet: interplay between protrusion activity and adhesion determines cell motion”
Search Results for:
IBEC wins funding from FECYT for outreach activities
The Fundación Española para la Ciencia y la Tecnología (FECYT) received 881 proposals from 383 public and private organisations for the call, which offers a total funding pot of €3,25 million for ideas and activities aimed at the promotion of scientific culture, technology and innovation.
IBEC group to receive Marató funding for Parkinson’s research
IBEC’s Molecular and Cellular Neurobiotechnology group is to receive funding from 2013’s La Marató de TV3 for their project “Role of the cellular prion protein as “cross-talk” protein between a-syn/ LRRK2 and p-Tau in sporadic and familiar Parkinson´s disease.”
The group’s proposal was one of 44 selected for funding under the annual award, which in its 2013 call focused on neurodegenerative diseases.
IBEC awarded funds to help researchers towards H2020 success
IBEC is one of 34 organisations in the entire country to be awarded funding under the 2013 ‘Acciones de Dinamización Europa Redes y Gestores’ programme of MINECO, Spain’s Ministry of Economy and Competitivity, to increase the capabilities of its Project Management Office (PMO).
Not only that, but the institute was ranked top among the applicants, meaning it will receive one of the two largest portions of the total grant money, the other going to the ISCIII.
IBEC group leader to give public lecture on stem cells
Tomorrow night IBEC group leader and ICREA professor Ángel Raya will give a public lecture at the CCCB in Barcelona entitled “Células madre y medicina regenerativa: realidades y promesas” (“Stem cells and regenerative medicine: realities and promises”).
Ángel, who is also director of the Barcelona Centre for Regenerative Medicine (CMRB), is contributing the lecture as part of the fourth ICREA-CCCB Debates series, taking place from 21 October to 11 November, which this year is devoted to “Stem Cells: a Future without Diseases?”.
Master students
The Institute for Bioengineering of Catalonia (IBEC) is looking for Master candidates to apply for Master fellowships within the IBEC Master Programme for 2025. IBEC launches the 9th call of the Master Programme … Read more
Market-driven technology transfer
IBEC is committed to turning research results into practical applications, providing innovative solutions to industry and to hospitals, and, ultimately, to society. We carry out Market-Driven Technology Transfer, managing our … Read more
IBEC’s platforms recognised in new ICTS map of cutting-edge research services in Spain
IBEC’s Core Facilities have been included in MINECO’s updated ICTS (Infraestructuras Científicas y Técnicas Singulares) map as part of NANBIOSIS, an integrated platform for research-oriented medical applications.
IBEC’s Core Facilities have been included in MINECO’s updated ICTS (Infraestructuras Científicas y Técnicas Singulares) map as part of NANBIOSIS, an integrated platform for research-oriented medical applications. Created by combining the service platforms within the CIBER-BBN and CCMIJU (the Center for Minimally Invasive Surgery Jesus Uson), NANBIOSIS (Infraestructuras Integrada de Producción y Caracterización de Nanomateriales, Biomateriales y Sistemas en Biomedicina) aims to be a ‘one-stop-shop’ service facility for the design and production of biomaterials and nanomaterials, among other applications.
“Investing in the future”
Josep A. Planell, rector of the UOC and Research Fellow at IBEC, appears in a new documentary about technology transfer in Catalonia, Inversió de Futur.
Presented by Pere Estupinyà, the hour-long documentary, made in by Televisió de Catalunya in collaboration with the CERCA centers, also features other notable names in the Catalan research arena, such as Hble. Sr. Andreu Mas-Colell and director of the PCB Montserrat Vendrell.
Presenting IBEC projects and Core Facilities at major chemistry show
IBEC is participating this week in Expoquimia, the international chemistry trade show whose 17th edition is taking place from 30 September to 3 October at the Fira Gran Via in Barcelona.
Expoquimia is attended by the leading companies and organizations in the international chemical industry such as BASF, BAYER, Dow Chemical, ICL, REPSOL and SOLVAY. The Fira’s three halls open their doors at 10am today, kicking off a program of workshops, seminars and conferences, as well as the trade exhibition.